Lower <i>SYNJ2BP</i> Gene Expression Is Associated With Poor Survival Outcome and Treatment Response in Clear Cell Renal Cell Carcinoma: A Bioinformatics Analysis
SYNJ2BP is a novel prognostic biomarker for ccRCC and the down-regulation of <i>SYNJ2BP</i> expression is associated with poor survival outcomes and reduced treatment response.
Authors
- Jordan Reynolds (ORCID: https://orcid.org/0000-0001-7455-6122)
- Tamiel N. Turley (ORCID: https://orcid.org/0000-0002-3326-5182)
- Simone O. Heyliger (ORCID: https://orcid.org/0000-0001-6595-2721)
- Emanuela Taioli (ORCID: https://orcid.org/0000-0001-5734-4806)
- Romonia R. Reams (ORCID: https://orcid.org/0000-0003-0460-0698)
- Marilyn D. Saulsbury
- Adam M. Kase (ORCID: https://orcid.org/0000-0002-1862-8467)
- John A. Copland (ORCID: https://orcid.org/0000-0001-5091-6242)
Institutions
- Hampton University (US)
- Jacksonville College (US)
- Tisch Hospital (US)
- Mayo Clinic in Florida (US)
- Florida Agricultural and Mechanical University (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Cancer Genomics & Proteomics
- Published
- 2025-10-28
- DOI
- https://doi.org/10.21873/cgp.20543
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institutes of Health
- National Cancer Institute